首页> 外国专利> Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer

Method and composition for the treatment of cancer by the enzymatic conversion of soluble radioactive toxic agents into radioactive toxic precipitates in the cancer

机译:通过将可溶性放射性有毒物质酶促转化为癌症中的放射性有毒沉淀物来治疗癌症的方法和组合物

摘要

A method for the treatment of cancer is disclosed which is capable of directing supra-lethal doses of radiation, called Hot-Spots, virtually exclusively to the cancer. The present invention involves a multi-step therapy process and includes a class of novel chemical agents. In accordance with the present invention, it was discovered that soluble precipitable materials can be made to accumulate as non-digestible precipitates in targeted cells as a result of enzyme action within the targeted cells. Accumulation is achieved by administering to the living host a soluble binary reagent made by attaching a targeting agent to a novel chemical agent which is a soluble precipitable material. The binary reagent binds to antigenic receptors on targeted cells which endocytose the binary reagent and transport it into the lysosomes where enzymes detach the soluble precipitable material from the targeting agent, causing it to precipitate, accumulate, and be retained in the cells. Increasing amounts of precipitate can be made to accumulate in cells by continuing the administration of the binary reagent. The accumulated precipitate is relocated to the extra-cellular fluid by selectively killing a fraction of cancer cells. Now relocated in the extra-cellular fluid of the cancer, the precipitate is used as a “platform” from which to generate Hot-Spots. A bispecific reagent with a non-mammalian enzyme moiety is made to bind to the precipitate. A soluble radioactive material is administered which is converted by the enzyme moiety of the bound bispecific reagent into a new form which is retained adjacent to the precipitate for an extended period of time, thereby generating Hot-Spots which non-selectively kill all cells adjacent to the precipitate in the extra-cellular fluid of the cancer.
机译:公开了一种用于治疗癌症的方法,该方法实际上能够将超致命剂量的辐射(称为热点)定向到癌症。本发明涉及多步骤治疗方法,并且包括一类新型化学试剂。根据本发明,发现由于靶细胞内的酶作用,可溶解的可沉淀物质可作为不可消化的沉淀物积聚在靶细胞中。通过向活体宿主施用可溶的二元试剂来实现积累,该二元试剂是通过将靶向剂附着到新型化学试剂上而制成的,该新型化学试剂是可溶的可沉淀物质。二元试剂与靶向细胞上的抗原受体结合,后者将二元试剂内吞并将其运输到溶酶体中,在酶中酶将可溶性可沉淀物质从靶向剂中分离出来,使其沉淀,积聚并保留在细胞中。通过继续施用二元试剂,可以使越来越多的沉淀物积聚在细胞中。通过选择性杀死一部分癌细胞,将积累的沉淀物重新定位到细胞外液中。现在该沉淀物重新定位在癌症的细胞外液中,被用作“平台”。从中生成热点。使具有非哺乳动物酶部分的双特异性试剂与沉淀物结合。施用可溶性放射性物质,其通过结合的双特异性试剂的酶部分转化为新形式,该新形式在沉淀附近保留一段较长的时间,从而产生热点,该热点非选择性地杀死所有与之相邻的细胞癌细胞的细胞外液中的沉淀物。

著录项

  • 公开/公告号US2003068382A1

    专利类型

  • 公开/公告日2003-04-10

    原文格式PDF

  • 申请/专利权人 ROSE SAMUEL;

    申请/专利号US20020226288

  • 发明设计人 SAMUEL ROSE;

    申请日2002-08-22

  • 分类号A61K39/00;A61K9/50;

  • 国家 US

  • 入库时间 2022-08-22 00:07:47

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号